Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy [NA]
A completed clinical trial evaluating prone breath-hold technique to reduce cardiac and pulmonary radiation exposure in women receiving left…
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer [Phase 2]
Phase II open-label trial of Tarceva in women with metastatic, hormone- and HER2-negative breast cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX® [Phase 3]
Phase 3 trial comparing LY01005 to ZOLADEX in breast cancer completed, reporting efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum [NA]
A completed clinical trial studying MRI to detect heart damage in cancer patients receiving chemotherapy, with an exercise capacity addendum…
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: A Study With Pembrolizumab in Combination With Dual Anti-HER2 Blockade With Trastuzumab and Pertuzumab in Early Breast Cancer Patients With Molecular HER2-enriched Intrinsic Subtype (Keyriched-1) [Phase 2]
Phase 2 trial evaluating pembrolizumab with dual anti-HER2 blockade (trastuzumab and pertuzumab) in early breast cancer with HER2-enriched s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases [Phase 2]
Phase II study update for T-DX in HER2-positive breast cancer with brain metastases has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study [NA]
Feasibility study of a novel MRI sequence (MR Fingerprinting) in breast MRI for breast screening; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer [Phase 3]
Phase 3 trial update for GB491 in combination with letrozole in HR-positive, HER2-negative advanced breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2023-05-08Clinical Trial Update: Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives) [NA]
Clinical trial update for a feasibility pilot study evaluating a 'Sit Less, Move More' app for Black breast cancer survivors and at-risk rel…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial update evaluating trastuzumab emtansine in Chinese patients with HER2-positive locally advanced or metastatic breast cancer ha…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE [Phase 2]
Phase 2 trial of RTA 408 Lotion in breast cancer patients at risk for radiation dermatitis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Compare Outcomes Between Two Acellular Dermal Matrices [Phase 2]
Phase 2 clinical trial comparing outcomes between two acellular dermal matrices in breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating letrozole in combination with sorafenib for metastatic breast cancer has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer. [Phase 3]
Phase 3 trial comparing Carelizumab plus nab-paclitaxel with/apatinib, Carelizumab plus nab-paclitaxel, and nab-paclitaxel in advanced tripl…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating SHR6390 with Pyrotinib for HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Breast Cancer - Anti-Progestin Prevention Study 1 [Phase 2]
Phase 2 clinical trial update for anti-progestin prevention in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast Cancer [Phase 3]
Phase 3 trial evaluating adjuvant pyrotinib in combination with trastuzumab for HER2-positive invasive breast cancer; not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Comparing the Perioperative Analgesic Effect of Two Different Volumes of Local Anesthetic Solution in Erector Spinae Plane Block in Patients Undergoing Modified Radical Mastectomy [Phase 2, Phase 3]
Phase 2/3 trial comparing two volumes of local anesthetic for erector spinae plane block in patients undergoing modified radical mastectomy;…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: IGF Level in Breast Cancer Patients Treated With Metformin [Phase 4]
Phase 4 clinical trial update investigating IGF level changes in breast cancer patients treated with metformin.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer [Phase 4]
Phase 4 trial comparing intravenous versus oral 5-HT3 antagonists combined with NK-1 receptor antagonists for prevention of chemotherapy-ind…
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: Intraoperative Detection of Residual Cancer in Breast Cancer [Phase 2]
Phase 2 clinical trial updating on intraoperative detection of residual cancer in breast cancer; results have been posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Long-term Outcomes of Breast Cancer Patients After Wound Infiltration Analgesia [Phase 4]
Phase 4 trial update reporting long-term outcomes after wound infiltration analgesia in breast cancer surgery patients, focusing on postoper…
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]
A combined Phase 1/2 study investigates epothilone D with Herceptin (trastuzumab) in HER-2 positive advanced or metastatic breast cancer; st…
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Breast Cancer Study of Preoperative Pembrolizumab + Radiation [Phase 1, Phase 2]
Update on a breast cancer trial evaluating preoperative pembrolizumab with radiation across Phase 1 and Phase 2, with results posted and the…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients [Phase 2]
Phase 2 trial update evaluating second-line therapy with ERIbulin followed by capecitabine or the reverse sequence in HER2-negative metastat…